Biosimilars pass their decade test as regulators settle the safety question

EURACTIV - Ten years after the first etanercept biosimilar was launched in Europe, regulators, registry data and practising clinicians have arrived at a common position: approved biosimilars work as well as the medicines they copy, and they widen access to them.  Read more

Getty Images | Catherine Falls Commercial